Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective (Q38949003)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 October 2015
edit
Language Label Description Also known as
English
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective
scientific article published on 29 October 2015

    Statements

    Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective (English)
    Stéphane Roze
    Jayne Smith-Palmer
    William J Valentine
    Mark Cook
    Manisha Jethwa
    Simona de Portu
    John C Pickup
    29 October 2015
    236-242

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit